Editor's Note: For more Foundation news, research updates and tips on living well with Parkinson's, read the Fall/Winter 2016 edition of The Fox Focus, our biannual newsletter.
Developing new treatments for a complex brain disorder such as Parkinson's takes a long time. As anyone with the condition (or a loved one who has been diagnosed) will tell you, it takes too long. The Michael J. Fox Foundation's mission is to speed the process up, and we can move ahead faster by working together. Through collaboration with drug developers, government, and, most importantly, people living with Parkinson's and their families, we can push closer to urgently needed breakthroughs.
We work with companies and academic groups to support their projects and help them move closer to or through clinical testing. Many of these partners -- including a handful with therapies to slow or stop disease progression -- are advancing new therapies toward patient hands. Read more in our latest newsletter cover story about how our de-risking model is enabling further development of these potential treatments.
Proving a drug is effective for Parkinson's is not the last step to getting it to patients, though. Here, we outline priorities of our new policy program. Working with federal and state regulators and lawmakers can help us speed new treatments to patients and improve access to care.
No matter what we do, we can never achieve our goals without you -- the vibrant and proactive Parkinson's community. Whether browsing Fox Trial Finder for trials in your area, registering with our online study Fox Insight or checking if you're eligible for the Parkinson's Progression Markers Initiative, there are many ways to partner with researchers toward deeper understanding of Parkinson's and better treatments. Advocating for public policy to support research and access to services or hosting a Team Fox fundraiser also advance the field toward our shared goals.
You can help us grow the momentum we've already built together.
Step into the story of how Parkinson's will ultimately be cured. Thank you for your partnership as we work tirelessly to reach a world without Parkinson's disease, as fast as we can.